Tag: Isatuximab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Isatuximab

FDA Requests Belantamab Mafodotin for R/R Multiple Myeloma Be Pulled From US Market

Added to Collection on: 2022-11-22 23:02:40

Tags for this article:

Drugs
Orphan drugs
Medicine
Clinical medicine
Daratumumab
Bortezomib
Pomalidomide
Multiple myeloma
Proteasome inhibitor
Dexamethasone
Isatuximab
Carfilzomib

Click the tags to see associated articles and topics

View Article Details
[Updated] CD38 Monoclonal Antibodies Market 2023 | Revenue Analysis and Industry Forecast

Added to Collection on: 2023-09-29 18:44:13

Tags for this article:

Immunology
Orphan drugs
Glycoproteins
Biotechnology
CD38
Isatuximab
Daratumumab
Monoclonal antibody
Antibody

Click the tags to see associated articles and topics

View Article Details
Patient-Centric Care in R/R MM - Cancer Network

Added to Collection on: 2024-02-01 21:43:26

Tags for this article:

Orphan drugs
Multiple myeloma
Daratumumab/hyaluronidase
Daratumumab
Teclistamab
Talquetamab
Idecabtagene vicleucel
Genmab
Isatuximab

Click the tags to see associated articles and topics

View Article Details
City of Hope scientists devise novel strategy to seek and destroy leukemia stem cells

Added to Collection on: 2024-02-26 18:42:17

Tags for this article:

Clusters of differentiation
CD38
Glycoproteins
Cell biology
Acute myeloid leukemia
Stem cell
Leukemia
Multiple myeloma
Isatuximab
Cancer stem cell
John C. Williams
United States

Click the tags to see associated articles and topics

View Article Details
Isa-EloPD Shows Promise in Multiple Myeloma Management - Targeted Oncology

Added to Collection on: 2024-02-28 18:07:51

Tags for this article:

Orphan drugs
Elotuzumab
Isatuximab
Multiple myeloma
Cereblon E3 ligase modulator
Lenalidomide
Pomalidomide
CD38
Selinexor
Daratumumab
Dexamethasone

Click the tags to see associated articles and topics

View Article Details
Myeloma: VRd Plus Isatuximab Improves Outcomes | MDedge Hematology and Oncology

Added to Collection on: 2024-06-11 18:36:34

Tags for this article:

Orphan drugs
Isatuximab
Multiple myeloma
CD38
Thierry Facon

Click the tags to see associated articles and topics

View Article Details
EHA 2024: Monoclonal antibodies continue to dominate multiple myeloma treatments

Added to Collection on: 2024-06-21 22:47:30

Tags for this article:

Orphan drugs
Isatuximab
Multiple myeloma
Pomalidomide
Daratumumab
Lenalidomide
Dexamethasone
Bortezomib
Selinexor
Elotuzumab

Click the tags to see associated articles and topics

View Article Details
BENEFIT Trial Results Show Quadruplet Regimen for NDMM TI May Require Weighing ...

Added to Collection on: 2024-06-22 11:23:43

Tags for this article:

Orphan drugs
Multiple myeloma
Bortezomib
Isatuximab
Lenalidomide
Peripheral neuropathy
Minimal residual disease
Progression-free survival
Dexamethasone
AUSTIN
James A. Davis

Click the tags to see associated articles and topics

View Article Details
Multiomic Perspective on CD38 Regulation and Targeting Offers New Insights for Treatment ...

Added to Collection on: 2024-08-06 20:50:34

Tags for this article:

Orphan drugs
Clusters of differentiation
CD38
Glycoproteins
Immune system
Immunology
Isatuximab
Daratumumab
Multiple myeloma
Genmab
Monoclonal antibody
Bispecific monoclonal antibody

Click the tags to see associated articles and topics

View Article Details
Blenrep shows overall survival benefit in head-to-head DREAMM-7 phase III trial for ...

Added to Collection on: 2024-11-15 10:22:01

Tags for this article:

Orphan drugs
B-cell maturation antigen
Belantamab mafodotin
Multiple myeloma
Daratumumab
Antibody-drug conjugate
Pomalidomide
Seagen
Bortezomib
Monomethyl auristatin F
Isatuximab
Daratumumab/hyaluronidase
gsk plc

Click the tags to see associated articles and topics

View Article Details